<?xml version='1.0' encoding='UTF-8'?>

      <!-- iXBRL document created with: Toppan Merrill Bridge iXBRL 10.1.0.3 -->
      <!-- Based on: iXBRL 1.1 -->
      <!-- Created on: 1/5/2023 11:18:56 AM -->
      <!-- iXBRL Library version: 1.0.8263.24741 -->
      <!-- iXBRL Service Job ID: 42c3f523-8916-4b06-b291-76b9a6fb8623 -->

  <html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:thrx="http://theseusrx.com/20230105" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrli="http://www.xbrl.org/2003/instance"><head><meta http-equiv="content-type" content="text/html" /><title></title></head><body><div style="margin-top:30pt;"></div><div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:EntityCentralIndexKey" id="Tc_99I8rpPXdkih6G0bV_e7pA_2_1">0001745020</ix:nonNumeric><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:AmendmentFlag" id="Tc_6NulFMKq_EehBq60AM2jhw_3_1">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="thrx-20230105.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001745020</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-05</xbrli:startDate><xbrli:endDate>2023-01-05</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div style="max-width:100%;padding-left:5.88%;padding-right:5.88%;position:relative;"><div style="clear:both;max-width:100%;position:relative;min-height:12.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:1pt;padding-top:1pt;text-align:center;border-bottom:1.0pt solid #000000;border-top:3.0pt solid #000000;margin:0pt;"><span style="display:inline-block;text-align:left;text-indent:0pt;width:36pt;"></span><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:5pt;font-weight:bold;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><a id="_2b2e6276_fac6_48ff_b0d7_e67fded141d8"></a><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:18pt;font-weight:bold;">UNITED STATES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Washington, D.C. 20549</b></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11.0pt;margin-bottom:6pt;min-height:1.28em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:89.87%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:18pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">FORM&#160;</b><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:DocumentType" id="Narr_b2eEMfwfnEqE5Qo-hOuhug"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">8-K</b></ix:nonNumeric></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11.0pt;margin-bottom:6pt;min-height:1.28em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:89.87%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">CURRENT REPORT</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d)</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 7pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">of the Securities Exchange Act of 1934</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:12pt;font-weight:bold;">Date of Report (Date Earliest Event Reported):</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:12pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="Narr_dDSzfXXwREquW5OGusG-_w"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">January 5, 2023</b></ix:nonNumeric></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11.0pt;margin-bottom:6pt;min-height:1.28em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:89.87%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:24pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:EntityRegistrantName" id="Narr_wImcb5EOmkCB77OtxnaWaA"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Theseus Pharmaceuticals,&#160;Inc.</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(Exact name of registrant as specified in its charter)</b></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11.0pt;margin-bottom:8pt;min-height:1.28em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:89.87%;border:none;margin:0 auto;"><a id="_0f638e38_a784_4973_9540_b6c9c7d9096b"></a><a id="Tc_Dv28VOhQlE6klsNGGfIXnQ_2_0"></a><a id="Tc_tBrItn8iP0qs11mwlvRXWQ_2_2"></a><a id="Tc_erSFRw1wnECxS0o5AuN2Mw_2_4"></a></div></div><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:32.56%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.2%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:30.51%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.17%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:30.53%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:32.56%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="Tc_IvRCdNcWq0WsvjREP6UUwg_1_0"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Delaware</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:3.2%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:top;width:30.51%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:EntityFileNumber" id="Tc_aFW_9l6IoUKw9gY01eq6zw_1_2"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">001-40869</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:3.17%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:top;width:30.53%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:EntityTaxIdentificationNumber" id="Tc_r8NuzV2E1UC8Xazl3f3lsw_1_4"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">83-0712806</b></ix:nonNumeric></p></td></tr><tr><td style="vertical-align:top;width:32.56%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(State or Other Jurisdiction</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">of Incorporation)</b></p></td><td style="vertical-align:bottom;width:3.2%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:30.51%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(Commission File Number)</b></p></td><td style="vertical-align:bottom;width:3.17%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:30.53%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(IRS Employer Identification No.)</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:5pt;visibility:hidden;">&#8203;</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0.5pt;padding-right:0.5pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:49.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:49.16%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:EntityAddressAddressLine1" id="Narr_E6iesPt2VEKoBHNHmNQMkg"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">314 Main Street</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:EntityAddressCityOrTown" id="Narr_n6EV_Z2o1kqB8-DyQOy8oA"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Cambridge</b></ix:nonNumeric><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">, </b><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="Narr_I3P5VlrdSUuRt5pKAq7YDg"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Massachusetts</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(Address of Principal Executive Offices)</b></p></td><td style="vertical-align:top;width:2.77%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:top;width:48.05%;margin:0pt;padding:0pt 0.5pt 0pt 0.5pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:EntityAddressPostalZipCode" id="Narr_eWWA5squh0ysjV8YRuBAGw"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">02142</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 8pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(Zip Code)</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:5pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">(</b><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:CityAreaCode" id="Narr_fNoeJTw2n0afoXp69Jdx5A"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">857</b></ix:nonNumeric><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">) </b><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:LocalPhoneNumber" id="Narr_vKS_NeQL0UyqY0wkdCcyFQ"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">400-9491</b></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(Registrant&#8217;s telephone number, including area code)</b></p><div style="font-family:'Calibri','Helvetica','sans-serif';font-size:11.0pt;margin-bottom:8pt;min-height:1.28em;position:relative;width:100%;"><div style="background-color:#000000;height:1px;position:relative;top:0.6em;width:89.87%;border:none;margin:0 auto;"></div></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Check the appropriate box below if the Form&#160;8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></p><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="Narr_hE07wm-wxEu5Kx6NoETgNA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="Narr__GHacl9UikygsBUt3HP7HA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="Narr_JHIOwfDWzUu-4zy3y5ubiw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p></td></tr></table><table style="border-collapse:collapse;border:0;"><tr><td style="vertical-align:text-top;white-space:nowrap;width:18pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="Narr_rggg06uZ7U2xLvaBCoYozA"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:0pt;margin-top:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))</span></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:6pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Securities registered pursuant to Section&#160;12(b)&#160;of the Act:</span></p><a id="_94301032_bffa_42f4_854f_a24a2c793ff5"></a><a id="Tc_Z5-QtLF_t0unPZ0-DDBqeA_1_0"></a><a id="Tc_T8JxMJM3zEyp18AzoTLSsw_1_2"></a><a id="Tc_MEapYpXOsEqnsqt1RVx76Q_1_4"></a><a id="Tc_os_l_QkopkGweSp4zUHu0Q_2_4"></a><table style="border-collapse:collapse;font-size:16pt;height:max-content;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:32.5%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.2%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:30.55%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 1.5pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:3.17%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:bottom;width:30.55%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:center;margin:0pt 0pt 1.5pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:32.5%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt 0pt 2pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Title of each class</b></p></td><td style="vertical-align:bottom;width:3.2%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 2pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:30.55%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Trading</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 1.5pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Symbol(s)</b></p></td><td style="vertical-align:bottom;width:3.17%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 2pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;&#160;&#160;&#160;</span></p></td><td style="vertical-align:bottom;width:30.55%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:center;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Name of each exchange on</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 1.5pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">which registered</b></p></td></tr><tr><td style="vertical-align:top;width:32.5%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 2pt 0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:Security12bTitle" id="Tc_Gzi8GrEtDUuYgBHw2i7SjQ_2_0"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Common stock, par value $0.0001 per share</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:3.2%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 2pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:30.55%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 2pt 0pt;"><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" name="dei:TradingSymbol" id="Tc_QCuLHxA2s0-dm7dgVu01Gw_2_2"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">THRX</b></ix:nonNumeric></p></td><td style="vertical-align:bottom;width:3.17%;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt 0pt 2pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">&#160;</span></p></td><td style="vertical-align:top;width:30.55%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt 2.65pt 0pt 2.65pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:center;margin:0pt 0pt 2pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">The </b><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="Narr_-9D8Et7JWUqHpQPczosVeA"><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;">Nasdaq</b></ix:nonNumeric><b style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;"> Stock Market LLC</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.28;text-align:center;margin:0pt 0pt 1.5pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">(Nasdaq Global Select Market)</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:5pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:6pt 0pt 6pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">Emerging growth company&#160;&#160;&#160;</span><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="Narr_EQtDFh9yeE6BdOCBjBOSLw"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9746;</span></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.&#160;&#160;&#160;</span><ix:nonNumeric contextRef="Duration_1_5_2023_To_1_5_2023_XqqshwnkHEK4naBJqeKYdA" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="Narr_Xe39SnMeCEGvKHYfuBYM6g"><span style="font-family:'Segoe UI Symbol';font-size:10pt;">&#9744;</span></ix:nonNumeric></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:5pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;padding-bottom:1pt;padding-top:1pt;text-align:justify;border-bottom:3.0pt solid #000000;border-top:1.0pt solid #000000;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="display:none;line-height:0pt;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:0pt;line-height:1.28;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:88.24%;border:0;margin:30pt 5.88% 30pt 5.88%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_e08e2497_915b_4516_b48b_01e0e1db4de8"></a><table style="border-collapse:collapse;border:0;"><tr><td style="width:2pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:64.15pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Item 2.02</b></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;background:#ffffff;">Results of Operations and Financial Condition.</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin-bottom:10pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;background:#ffffff;margin:0pt 0pt 10pt 0pt;">On January 5, 2023, Theseus Pharmaceuticals,&#160;Inc. (the &#8220;Company&#8221;) released a corporate presentation which contained information regarding the Company&#8217;s preliminary, unaudited estimate of cash, cash equivalents and marketable securities as of December 31, 2022 of approximately $211.8 million. </p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">The financial results included in the corporate presentation are unaudited and preliminary estimates that (i) represent the most current information available to management as of the date of this Current Report on Form 8-K, (ii) are subject to completion of financial closing and procedures that could result in significant changes to the estimated amounts, and (iii) do not present all information necessary for an understanding of the Company&#8217;s financial condition as of and its results of operations for the year ended December 31, 2022. Accordingly, undue reliance should not be placed on such preliminary estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">&#160;</p><p style="font-family:'Times New Roman','Times','serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;">In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02 shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company&#8217;s filings under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.</p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;padding-left:64.35pt;text-indent:-64.35pt;margin:0pt 0pt 1.5pt 2pt;"><span style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_a2a01a94_cd21_4ba5_9e6d_d5af5612fb2a"></a><table style="border-collapse:collapse;border:0;"><tr><td style="width:2pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:64.15pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Item 7.01</b></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Regulation FD Disclosure</b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">.</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';background:#ffffff;">On January&#160;5, 2023, the Company issued a press release and released a corporate presentation that has been made available on the investor relations section of the Company&#8217;s website at https://ir.theseusrx.com/. The corporate presentation and the press release are furnished as Exhibits 99.1 and 99.2, respectively</span><span style="font-family:'Times New Roman','Times','serif';">.</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';background:#ffffff;">The information in Item 7.01 of this Current Report on Form&#160;8-K (including Exhibits&#160;99.1 and 99.2 attached hereto) are being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing by the Company, under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such filing</span><span style="font-family:'Times New Roman','Times','serif';">. </span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;padding-left:64.35pt;text-indent:-64.35pt;margin:0pt 0pt 1.5pt 2pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_33fa9982_9c88_40b3_8b8d_9ac4742645e8"></a><table style="border-collapse:collapse;border:0;"><tr><td style="width:2pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:64.15pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Item 8.01 </b></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Other Events.</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;visibility:hidden;background:#ffffff;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 1.5pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';background:#ffffff;">On January&#160;5, 2023, the Company issued a press release announcing key anticipated 2023 milestones and BCR-ABL as the target for the Company&#8217;s third development program. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K.</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;padding-left:64.35pt;text-indent:-64.35pt;margin:0pt 0pt 1.5pt 2pt;"><span style="font-family:'Times New Roman','Times','serif';font-weight:bold;margin-bottom:8pt;margin-left:0pt;visibility:hidden;">&#8203;</span></p><a id="_86cee706_00a9_4f4a_8260_43ab3f319890"></a><table style="border-collapse:collapse;border:0;"><tr><td style="width:2pt;padding:0pt;"></td><td style="vertical-align:text-top;white-space:nowrap;width:64.15pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Item 9.01</b></p></td><td style="padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin-bottom:1.5pt;margin-top:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Financial Statements and Exhibits.</b></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">(d)&#160;Exhibits</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:7.42%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td><td style="vertical-align:top;width:2.47%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"></div></div></td><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"></div></div></td></tr><tr><td style="vertical-align:bottom;width:7.42%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">No.</b></p></td><td style="vertical-align:top;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">&#160;&#160;&#160;&#160;</b></p></td><td style="vertical-align:bottom;width:90.09%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Description of Exhibit</b></p></td></tr><tr><td style="vertical-align:bottom;width:7.42%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">99.1</span></p></td><td style="vertical-align:top;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:90.09%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="thrx-20230105xex99d1.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Theseus Pharmaceuticals, Inc. Corporate Presentation, dated January 5, 2023</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">99.2</span></p></td><td style="vertical-align:top;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><a style="-sec-extract:exhibit;font-family:&quot;'Times New Roman','Times','serif'&quot;;" href="thrx-20230105xex99d2.htm"><span style="font-family:'Times New Roman','Times','serif';font-style:normal;font-weight:normal;">Press release issued by Theseus Pharmaceuticals, Inc. on January 5, 2023</span></a></p></td></tr><tr><td style="vertical-align:bottom;width:7.42%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">104</span></p></td><td style="vertical-align:top;width:2.47%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:8pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:bottom;width:90.09%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td></tr></table><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;margin-bottom:8pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;page-break-after:always;width:76.47%;border:0;margin:30pt 11.76% 30pt 11.76%;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="clear:both;max-width:100%;position:relative;"><a id="_4a4455b8_fcbe_42eb_8691_22cb8ad1d8e3"></a><p style="font-family:'Calibri Light';font-size:11pt;font-weight:bold;line-height:1.19;text-align:center;margin:0pt 0pt 10pt 0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">SIGNATURES</b></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;text-align:justify;margin:0pt 0pt 10pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></p><div style="margin-left:0pt;"><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:100%;"><tr style="height:1pt;"><td style="vertical-align:top;width:44.14%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:4.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:7.61%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td><td style="vertical-align:top;width:43.5%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="position:absolute;top:0pt;width:100%;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:1pt;visibility:hidden;">&#8203;</span></p></div></div></td></tr><tr><td style="vertical-align:top;width:44.14%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:55.85%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Theseus Pharmaceuticals,&#160;Inc.</span></p></td></tr><tr><td style="vertical-align:top;width:44.14%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td><td colspan="3" style="vertical-align:top;width:55.85%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td></tr><tr><td style="vertical-align:top;width:44.14%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">By:</span></p></td><td colspan="2" style="vertical-align:top;width:51.12%;border-bottom:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">/s/ Bradford D. Dahms</span></p></td></tr><tr><td style="vertical-align:top;width:44.14%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:7.61%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Name:</b></p></td><td style="vertical-align:top;width:43.5%;border-top:1.0pt solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Bradford D. Dahms</span></p></td></tr><tr><td style="vertical-align:top;width:44.14%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:4.73%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';margin-bottom:10pt;visibility:hidden;">&#8203;</span></p></td><td style="vertical-align:top;width:7.61%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Title:</b></p></td><td style="vertical-align:top;width:43.5%;margin:0pt;padding:0pt;"><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Chief Financial Officer</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:10pt;line-height:1.19;text-align:justify;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">(Principal Financial and Accounting Officer)</span></p></td></tr></table></div><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';font-size:10pt;visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.19;margin:0pt;"><span style="font-family:'Times New Roman','Times','serif';">Date: January 5, 2023</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</span></p><p style="font-family:'Calibri','Helvetica','sans-serif';font-size:11pt;line-height:1.28;margin:0pt 0pt 8pt 0pt;"><span style="font-family:'Times New Roman','Times','serif';visibility:hidden;">&#8203;</span></p></div></div>
<div style="background-color:#000000;clear:both;height:2pt;margin-left:11.76%;margin-right:11.76%;margin-top:30pt;page-break-after:avoid;width:76.47%;border:0;"></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "thrx-20230105x8k.htm", "description": "8-K", "secsgml_size_bytes": 58982}]
{"company-data": {"conformed-name": "Theseus Pharmaceuticals, Inc.", "cik": "0001745020", "assigned-sic": "2834", "irs-number": "830712806", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-40869", "film-number": "23509706"}, "business-address": {"street1": "314 MAIN STREET, SUITE 04-200", "city": "CAMBRIDGE", "state": "MA", "zip": "02142", "phone": "(857) 400-9491"}, "mail-address": {"street1": "314 MAIN STREET, SUITE 04-200", "city": "CAMBRIDGE", "state": "MA", "zip": "02142"}}
​
​
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date Earliest Event Reported):
January 5, 2023
Theseus Pharmaceuticals, Inc.
(Exact name of registrant as specified in its charter)
​
​
​
​
​
Delaware
001-40869
83-0712806
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
​
​
​
​
​
​
​
314 Main Street
Cambridge
,
Massachusetts
(Address of Principal Executive Offices)
02142
(Zip Code)
​
(
857
)
400-9491
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))
Securities registered pursuant to Section 12(b) of the Act:
​
​
​
​
​
​
​
Title of each class
Trading
Symbol(s)
Name of each exchange on
which registered
Common stock, par value $0.0001 per share
THRX
The
Nasdaq
Stock Market LLC
(Nasdaq Global Select Market)
​
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
​
​
Item 2.02
Results of Operations and Financial Condition.
​
On January 5, 2023, Theseus Pharmaceuticals, Inc. (the "Company") released a corporate presentation which contained information regarding the Company's preliminary, unaudited estimate of cash, cash equivalents and marketable securities as of December 31, 2022 of approximately $211.8 million.
The financial results included in the corporate presentation are unaudited and preliminary estimates that (i) represent the most current information available to management as of the date of this Current Report on Form 8-K, (ii) are subject to completion of financial closing and procedures that could result in significant changes to the estimated amounts, and (iii) do not present all information necessary for an understanding of the Company's financial condition as of and its results of operations for the year ended December 31, 2022. Accordingly, undue reliance should not be placed on such preliminary estimates.
In accordance with General Instruction B.2. of Form 8-K, the information in this Item 2.02 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any of the Company's filings under the Securities Act of 1933, as amended (the "Securities Act"), whether made before or after the date hereof, regardless of any incorporation language in such a filing, except as expressly set forth by specific reference in such a filing.
​
Item 7.01
Regulation FD Disclosure
.
​
On January 5, 2023, the Company issued a press release and released a corporate presentation that has been made available on the investor relations section of the Company's website at https://ir.theseusrx.com/. The corporate presentation and the press release are furnished as Exhibits 99.1 and 99.2, respectively
.
The information in Item 7.01 of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2 attached hereto) are being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference into any filing by the Company, under the Securities Act, or the Exchange Act, except as expressly set forth by specific reference in such filing
.
​
Item 8.01
Other Events.
​
On January 5, 2023, the Company issued a press release announcing key anticipated 2023 milestones and BCR-ABL as the target for the Company's third development program. A copy of the press release is attached as Exhibit 99.2 to this Current Report on Form 8-K.
​
Item 9.01
Financial Statements and Exhibits.
​
(d) Exhibits
No.
Description of Exhibit
99.1
​
Theseus Pharmaceuticals, Inc. Corporate Presentation, dated January 5, 2023
99.2
​
Press release issued by Theseus Pharmaceuticals, Inc. on January 5, 2023
104
​
Cover Page Interactive Data File (embedded within the Inline XBRL document)
​
​
​
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
​
​
​
​
​
Theseus Pharmaceuticals, Inc.
​
​
​
By:
/s/ Bradford D. Dahms
​
​
Name:
Bradford D. Dahms
​
​
Title:
Chief Financial Officer
(Principal Financial and Accounting Officer)
​
Date: January 5, 2023
​
​